Company Filing History:
Years Active: 2006-2008
Title: Innovations by Philip W Garrett-Engele
Introduction
Philip W Garrett-Engele is an accomplished inventor based in Seattle, WA. He has made significant contributions to the field of nucleic acid research, holding two patents that showcase his innovative methods and discoveries. His work has implications for various applications in biotechnology and molecular biology.
Latest Patents
Garrett-Engele's latest patents include methods for preparing nucleic acid samples. One patent outlines a process that involves utilizing an RNA template to enzymatically synthesize a first DNA molecule, which is complementary to at least 50 contiguous bases of the RNA template. This method further includes steps to create a double-stranded DNA molecule and synthesize RNA molecules that are complementary to the DNA. Another patent features novel splice variant isoforms of acetyl-CoA carboxylase 2 (ACC2), providing nucleic acids and polypeptides that can be used to screen for compounds that bind to these variants.
Career Highlights
Philip Garrett-Engele is currently associated with Rosetta Inpharmatics, Inc., where he continues to advance his research in nucleic acids. His work has been pivotal in enhancing the understanding of genetic materials and their applications in health and disease.
Collaborations
Throughout his career, Garrett-Engele has collaborated with notable colleagues, including Christopher D Armour and Daniel D Shoemaker. These collaborations have fostered a productive environment for innovation and